Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

THIOPENTAL for Foetal exposure during pregnancy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 29 adverse event reports in the FDA FAERS database where THIOPENTAL was used for Foetal exposure during pregnancy.

Most Reported Side Effects for THIOPENTAL

Side Effect Reports % Deaths Hosp.
Drug ineffective 266 25.4% 57 168
Off label use 150 14.3% 52 93
Status epilepticus 93 8.9% 44 54
Hypotension 82 7.8% 16 35
Maternal exposure during pregnancy 74 7.1% 17 26
Foetal exposure during pregnancy 70 6.7% 28 10
Exposure during pregnancy 64 6.1% 7 26
Product use in unapproved indication 63 6.0% 24 37
Diabetes insipidus 55 5.3% 29 18
Drug hypersensitivity 45 4.3% 0 13
Loss of consciousness 44 4.2% 15 28
Seizure 44 4.2% 18 29
Multiple-drug resistance 43 4.1% 12 23
Intensive care unit acquired weakness 41 3.9% 14 41
Foetal death 40 3.8% 14 17

Other Indications for THIOPENTAL

Status epilepticus (223) Induction of anaesthesia (163) Product used for unknown indication (114) Anaesthesia (105) Seizure (88) Endotracheal intubation (68) General anaesthesia (56) Epilepsy (37) Sedation (29) New onset refractory status epilepticus (25)

Other Drugs Used for Foetal exposure during pregnancy

HYDROXYPROGESTERONE CAPROATE (4,042) ONDANSETRON (1,061) ASPIRIN (485) BETAMETHASONE (475) PREDNISONE (429) ACETAMINOPHEN (428) OXYCODONE (414) LEVETIRACETAM (401) TACROLIMUS (382) LAMOTRIGINE (343)

Related Pages

THIOPENTAL Full Profile All Foetal exposure during pregnancy Drugs THIOPENTAL Demographics THIOPENTAL Timeline